Articles tagged with Cancer Medication
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Researchers at University of Alabama at Birmingham discovered androgen receptor imports into mitochondria, where it regulates multiple mitochondrial processes. This finding may lead to new treatment targets for castration-resistant prostate cancer.
Scientists at the University of Wisconsin-Madison have discovered an unexpected regulator of the p53 protein, which plays a crucial role in cancer development. The research team found that an enzyme called PIPK1-alpha and its lipid messenger, PIP2, drive the stability of mutant p53, leading to cancer progression.
Research has led to increased understanding of genetic changes in cancer, highlighting the potential for personalized care in children with cancer. Genetic profiling can inform prognosis and treatment decisions, providing critical information about tumor progression and response.
Researchers at Stanford University School of Medicine have discovered a method to forecast which breast cancer patients will experience heart problems from trastuzumab, a commonly used chemotherapy drug. A class of medications already approved by the FDA may mitigate these side effects.
A new study shows that innovative communication programs can improve patients' mental health symptoms and quality of life. The program, which involves structured conversations between clinicians and patients, results in more timely and meaningful discussions about patient values and goals.
A study from MIT and Brigham and Women's Hospital found that nearly all pills and capsules contain ingredients that can cause allergic reactions or irritations in certain patients. The researchers aim to raise awareness of this issue and stimulate reforms to protect patients.
Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a distinct form of cancer linked to textured breast implants. Clear guidelines formalize treatment strategy, recommending surgical techniques like stepwise en bloc resection for complete oncologic resection and removal of involved lymph nodes.
A nationally representative study found that teenagers and young adults are more likely to use fruit- and candy-flavored e-cigarettes than their adult counterparts. The study also revealed that adolescent vapers were more likely to experiment with multiple flavor types, which may be a key factor in their vaping habits.
A new experimental drug, 673A, targets and annihilates stem-like ovarian cancer cells that cause recurrence. The treatment, combined with chemotherapy, resulted in significantly greater survival rates in a mouse model of ovarian cancer.
A team of scientists has discovered a unique genetic signature, or 'fingerprint', in cancer cells that can be targeted to selectively eliminate abnormal cells. This breakthrough could lead to more effective and less toxic cancer treatments.
PARP inhibitors have been found to enhance the immune response against cancer cells with DNA repair defects, suggesting a new approach to treating various types of cancer. This discovery could lead to increased effectiveness of immunotherapies and improved treatment outcomes for patients.
A study found that rural areas have higher levels of ambiguity and fatalism regarding cancer, which can discourage participation in screenings. Researchers hope to develop customized interventions based on community needs and values.
Researchers have discovered a potential treatment for cancer in patients with epidermolysis bullosa, a severe skin disease also known as butterfly disease. The new drug, rigosertib, was shown to be highly effective at killing cancer cells in preclinical studies and may target the cancer without harming healthy cells.
Researchers at Bar-Ilan University discovered the intricate molecular mechanism of the guidance receptor 'Robo', which reacts to signals in its environment while avoiding premature activity. The findings provide a basis for designing effective drugs targeting Robo receptors, potentially treating various neurological and cancer conditions.
Researchers at University of Tsukuba uncover how stratifin causes lung adenocarcinoma to emerge, identifying two drugs with other clinical uses that could be applied effectively in this disease. The study's findings raise hopes for more powerful treatment tools and value drug repositioning as a potential solution.
Researchers have found a pair of old drugs that can disrupt disease-causing pathways in triple negative breast cancer. Metformin and heme, previously used to treat diabetes and porphyria, were tested in mice and produced encouraging results when combined.
Researchers at The Wistar Institute have developed a drug candidate for EBV-associated cancers, inhibiting tumor growth in preclinical models. Pharmacological inhibition of EBNA1 had profound effects on gene expression, decreasing EBV DNA copy number and suppressing tumor-promoting pathways.
Researchers created metallocorrole/protein nanoparticles that can both survive longer in the body and better snipe disease targets. The theranostics have huge chemotherapeutic potential, potentially shortening treatment duration and diminishing side effects for cancer patients.
A new study by Boston University School of Public Health evaluates the Novartis Access program in Kenya, demonstrating that robust, 'gold standard' methods can be used to assess major pharmaceutical companies' access programs. The study found that the program significantly increased availability of two medicines in health facilities bu...
UC San Diego Health, Ochsner Health System, Sutter Health and Stanford Health Care developed diverse models of care incorporating patient-centered technologies with measurable outcomes. Technology improved medication adherence for hypertension and diabetes, reduced distress in cancer patients, and enhanced patient engagement.
Researchers identified S15 as a major immune suppressor in B7-H1-negative tumors resistant to current anti-PD therapies. A first-in-human Phase 1/2 clinical trial is underway for NC318, a monoclonal antibody targeting S15.
Despite the risks, many health care workers do not use recommended personal protective equipment when handling chemotherapy. A study from Michigan Medicine found that nurses who reported handling hazardous drugs had twice the risk of reproductive problems.
Ugur Sahin received the 2019 German Cancer Award for his pioneering research on individualized cancer immunotherapies. He is developing technologies to identify and exploit unique cancer characteristics to guide the immune system against specific tumors.
Researchers found that lung cancer cells acquire resistance to molecular-targeted drugs by transforming epithelial characteristics into mesenchymal ones, leading to reduced miR-200c expression. Sequential treatment with an HDAC inhibitor and a next generation molecular-targeted drug overcomes this resistance, offering new potential for...
Researchers at U of T Engineering created a 3D hydrogel to mimic lung cancer environments, selectively allowing cancer cells to invade. This technology enables rapid screening of hundreds of potential drugs for their ability to fight invasive cancers.
Researchers at UCLA have developed a method to screen hundreds of drugs in patients' own cells, creating miniature tumor organoids. This approach can help identify effective treatments for rare and hard-to-treat cancers, and could guide treatment decisions.
Cancer stem-cells are responsible for recurrence and drug resistance. MTHFD2, a mitochondrial metabolic enzyme, plays a critical role in maintaining CSCs by consuming AICAR, leading to depletion of the intracellular pool. Targeting MTHFD2 may eradicate tumors and prevent recurrence.
A clinical trial found sacituzumab govitecan produced a significant treatment response in patients with difficult-to-treat metastatic triple-negative breast cancer, outperforming standard chemotherapy. The drug showed manageable side effects and improved treatment duration.
A new 'smart drug', sacituzumab govitecan, has shown significant tumor shrinkage and improved patient outcomes in a clinical trial for women with metastatic triple-negative breast cancer. The treatment resulted in better response rates and longer overall survival compared to traditional therapies.
Researchers at Johns Hopkins Medicine have discovered a new compound called rapadocin that may prevent reperfusion injury, a tissue-damaging complication of surgery. The compound was found to block the activity of a chemical pathway associated with reperfusion injuries, reducing markers of kidney damage in mice.
The Mark Foundation has selected 14 new ASPIRE Award winners, funding high-risk, high-reward cancer research projects across the US and internationally. These projects focus on early cancer detection, immunotherapy, tumor microenvironment, and more, with the potential to advance cancer medicine.
A study by Cedars-Sinai Medical Center has identified a drug called dasatinib that could enhance the effectiveness of immunotherapies for various types of cancers. The researchers found that combining dasatinib with anti-PD-1 therapy increased sensitivity in cancer cells, making it a promising approach to improve treatment outcomes.
Researchers from the University of Sheffield discovered a compound that kills cancer cells without triggering apoptosis, making it resistant to treatment. The new drug lead is highly active against treatment-resistant cancers and may be particularly effective against ovarian cancer.
Researchers at CNIC identified a very early marker of cardiac damage in patients undergoing anthracycline therapy, allowing for early diagnosis and potential prevention of irreversible damage. The discovery has implications for patient prognosis and may lead to new therapies based on mitochondrial transplantation.
A phase 3 clinical trial found that a combination of two drugs, including an immunotherapy agent, significantly improved progression-free survival and response rates compared to a standard treatment. The results suggest that the new treatment may become a new standard for first-line treatment for patients with metastatic kidney cancer.
The open-science model is being expanded to neurodegenerative diseases such as Parkinson's and Amyotrophic Lateral Sclerosis. M4ND Pharma will pursue promising new genetic drug targets, sharing progress with the scientific community through regular online meetings.
Researchers are studying animal venoms to identify molecular targets for diseases such as osteoarthritis, rheumatoid arthritis, cancer, and neurodegenerative diseases. The study found promising antitumoral effects and potential new compounds that can be used as medicines.
A recent study published by The Endocrine Society found that oral complications are rare in women taking medications for postmenopausal osteoporosis. Despite concerns among dentists and patients, the rate of osteonecrosis of the jaw (ONJ) was low, with only 5.2 cases per 10,000 patient-years reported.
A new therapeutic target has been identified for aggressive pediatric cancers with few treatment options. The researchers discovered that malignant rhabdoid tumors may be sensitive to drugs that block the cancer cell's ability to dispose of misfolded proteins, and a Phase II clinical trial is underway to investigate this approach.
Researchers create 3D in vitro model capable of isolating specific metastatic cells, providing platform for identifying potential therapies and screening anticancer drugs. The model also enables study of interactions between vasculature and drugs, yielding important answers.
A UCLA-led study found that administering immunotherapy drug pembrolizumab before surgery significantly extended the lives of people with recurrent glioblastoma. The study showed that those who received the drug prior to surgery lived nearly twice as long after surgery compared to those who received it afterward.
Researchers at Karolinska Institutet develop new approach to targeted cancer treatment using Class Frizzled receptors, potentially effective against rectal and lung cancers. The study reveals molecular details of receptor activation and pathway selection.
A new cancer drug called tisotumab vedotin has shown significant promise in treating various types of cancer, with a response rate of up to 27% in patients with advanced, drug-resistant cancers. The treatment works by releasing a toxic substance to kill cancer cells from within and has manageable side effects.
Researchers at Scripps Research Institute have developed a new approach to shifting breast cancer cells into HER2-positive status using RNA-targeting precision medicines. The proof-of-concept study suggests that this technology could expand treatment options for patients with dwindling choices.
A study of 2,766 physicians found that those receiving payments from a cancer drug's manufacturer were more likely to prescribe the drug for certain types of cancer, including kidney and lung cancer. Financial relationships between physicians and drug companies can influence prescribing practices.
A multi-pronged effort will be launched to combat cervical cancer in Malawi, with a focus on early screening and same-day treatment of precancerous lesions using thermocoagulation. The project aims to increase the number of women screened and treated, and decrease loss to follow up.
A new study has identified a pair of genes that can mimic the effects of BRCA proteins, potentially making tumor cells susceptible to PARP inhibitors. The researchers found that targeting these genes could improve treatment options for people with breast or ovarian cancer caused by BRCA defects.
Researchers discovered how a metallodrug reaches cancer cells and attacks them efficiently. The molecule penetrates the cell membrane and targets essential organelles, leading to anticancer activity.
Cancer researchers have mapped oesophageal adenocarcinoma genes in unprecedented detail, unveiling more than half as potentially targetable by drugs already in trials for other cancers. This breakthrough could lead to personalized therapies and improved treatment options for patients.
Researchers at McGill University discovered a shared genetic marker that could effectively treat rare and common types of cancer, including ovarian and lung cancers. The breakthrough is based on targeting the cyclin-dependent kinases 4/6, which are vulnerable to existing drugs used in breast cancer treatment.
A recent study published in Human Reproduction found that children born after fertility treatment do not have an increased risk of developing cancer compared to those conceived naturally. However, some cancers, such as lymphoblastic leukemia and melanoma, were slightly more common in ART-conceived children, although the findings are st...
Researchers identified a crucial link between polyamines and the MYCN oncogene, revealing a new therapeutic approach to disrupt cancer cell growth. A combination therapy of DFMO and AMXT-1501 showed significant increase in survival in mice with established neuroblastoma tumours.
Scientists developed a new method to study ADP-ribosylation, a process linked to cancer growth and other diseases. The ELTA technique enables researchers to attach molecular beacons to ADP-ribose molecules, allowing for detailed studies on how this process affects cells in health and disease.
Researchers identify a new molecular pathway that suggests rapamycin, an anti-rejection medication, could be repurposed to treat certain liver cancers with β-catenin mutations. The study found that tumors are 'mTOR addicted' and can be inhibited by rapamycin, offering a precision medicine approach for improved treatment success.
A study of 28,000 childhood cancer survivors found that exposure to different anthracycline chemotherapies results in variable long-term cardiovascular risk. Specifically, daunorubicin was associated with decreased cardiomyopathy risk compared to doxorubicin, while mitoxantrone appeared to have greater long-term cardiomyopathy risk.
The Lung Cancer Master Protocol (Lung-MAP) is expanding to include patients with all types of advanced stage non-small cell lung cancers. This will allow thousands of new patients to enroll in the trial and benefit from investigational drugs, addressing a significant need for new treatments.
Drs. Silvia Formenti and Heather McArthur will collaborate on a year-long project using radiation and immunotherapy to create personalized vaccines for breast cancer patients. Their work aims to improve treatment outcomes and reduce mortality.
Scientists at CeMM Research Center have developed a method to identify promising drug combinations for chronic lymphocytic leukemia. By combining epigenetic analysis and high-throughput imaging, researchers can predict which drugs are likely to work together effectively, reducing trial-and-error approaches.
Researchers at Purdue University have developed a series of drug compounds that have shown promise in treating acute myeloid leukemia (AML), a type of blood cancer that is often lethal. The new compounds work on both common and drug-resistant forms of AML, including those with problematic mutations.
A new study found that extending medication time for varenicline to 24 weeks combined with 24 weeks of counseling sessions improves quitting success rates and reduces relapse risk in cancer patients. For those taking the medication as directed, quit rates increased significantly.